Skip to content
RetailOnline Retail

The Estée Lauder Companies’ Statement on Potential Transaction with Puig

The Estée Lauder Companies Inc. 2 mins read
NEW YORK--BUSINESS WIRE--

The Estée Lauder Companies Inc. (NYSE: EL) confirms that it is in discussions regarding a potential business combination with Puig, in which the two companies would potentially merge their businesses. No final decision has been made, and no agreement has been reached. Unless and until an agreement is signed between the companies, there can be no assurances regarding the deal or its terms.

Forward-Looking Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding a potential transaction and the anticipated timing, terms, and completion of any such transaction.

Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, among others, the possibility that no agreement will be reached, that required regulatory approvals may not be obtained, or that other conditions to a potential transaction may not be satisfied.

There can be no assurance that any transaction will be consummated or, if consummated, as to its timing or terms. The Estée Lauder Companies undertakes no obligation to update any forward-looking statements, except as required by law.

About The Estée Lauder Companies Inc.

The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.

ELC-C


Contact details:

Investor Relations:
Rainey Mancini
[email protected]

Media Relations:
Brendan Riley
[email protected]

Media

More from this category

  • RetailOnline Retail
  • 24/03/2026
  • 00:10
PDI Technologies

PDI Technologies Helps EMEA Retailers Operate Smarter at UNITI expo 2026

Returning as a Cooperation Partner, PDI showcases data-driven solutions and emerging AI capabilities that simplify operations, strengthen performance, and improve decision makingFRANKFURT, Germany, March 23, 2026 (GLOBE NEWSWIRE) -- PDI Technologies, a global leader enabling smarter operations across the convenience retail and energy sectors, today announced its return to UNITI expo 2026 as a Cooperation Partner. PDI will demonstrate how its connected ecosystem of solutions—supported by trusted operational data and practical applications of AI—helps businesses run smarter operations, improve visibility, and make clearer, more confident decisions.UNITI expo, Europe’s leading trade fair for the service station and car wash industries, brings…

  • RetailOnline Retail
  • 23/03/2026
  • 23:40
Manhattan Associates Inc.

Manhattan Associates’ 2026 Unified Commerce Benchmark Reveals the High Price of Standing Still in Retail

Leaders achieve up to 2X revenue growth, but only 7% of retailers are true unified commerce leaders ATLANTA--BUSINESS WIRE--Manhattan Associates Inc. (NASDAQ: MANH), today announced the findings of its 2026 Global Unified Commerce Benchmark for Specialty Retail, the industry’s most comprehensive assessment of how well retailers connect digital and physical experiences to drive growth, profitability and loyalty. Conducted by Incisiv, a leading retail research firm, the Benchmark is based on real-world purchases and returns. It analyzes more than 400 specialty retailers across EMEA, LATAM and North America on 330 capabilities spanning four key experience areas: Shopping, Checkout, Fulfillment, and Service.…

  • RetailOnline Retail
  • 23/03/2026
  • 17:11
Galderma

Galderma Receives U.S. FDA Approval for Restylane® Contour(TM) for the Correction of Temple Hollowing

The United States (U.S.) Food and Drug Administration (FDA) has approved Restylane Contour* for the correction of temple hollowing, expanding its use beyond cheek…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.